Pharmafile Logo
Pharmafocus logo
Advanced Search

BioNTech begins phase 1 trial for malaria vaccine

December 23, 2022
Medical Communications

BioNTech has announced the start of its new first-in-human phase 1 trial for BNT165b1, a candidate from its programme which …

News

Celltrion submits application for CT-P13 SC to FDA

December 23, 2022
Medical Communications

Celltrion has announced that it has finalised its submission of a biologics license application for the subcutaneous version of a …

News

Moderna signs ten-year deal with UK Government for vaccine production

December 23, 2022
Manufacturing and Production

US biotech company Moderna has finalised a partnership with the UK government to produce vaccines, the main element of which …

News

COVID-19 antiviral treatment shown to speed up recovery in trial

December 23, 2022
Medical Communications

Molnupiravir, made by Merck, Sharp and Dohme (MSD), has been found to reduce the recovery time of COVID-19 patients, however …

News

Treatment for rare, paediatric growth hormone deficiency recommended by NICE for use on the NHS

December 22, 2022
Medical Communications

Walton Oaks, 22 December 2022 – Pfizer Ltd today announces that the National Institute for Health and Care Excellence (NICE) …

News
Press release

AstraZeneca shares two new drug approvals in the EU

December 22, 2022
Medical Communications

On Wednesday, AstraZeneca announced two drug approvals in the European Union (EU). The first being Imfinzi’s approval for the treatment …

News

Everest Medicines and licensing partner Pfizer receive FDA and EMA approval for ulcerative colitis drug

December 22, 2022
Medical Communications

Everest Medicines, a biopharmaceutical company, has announced that its licensing partner, Pfizer, has received acceptance from the FDA for a …

News

New monoclonal antibody for hospitalised COVID-19 patients approved by FDA

December 22, 2022
Medical Communications

The FDA has approved Roche’s monoclonal antibody which treats hospitalised adult patients with COVID-19. The antibody, Actemra, is already approved …

News

Abiomed receives FDA approval for heart pump clinical trial

December 22, 2022
Research and Development

Abiomed, a leading provider of medical technology focusing on the circulatory system and oxygenation, has announced that the FDA has …

News

OSE Immunotherapeutics Announces First Patient Dosed with Anti-PD1 Monoclonal Antibody OSE-279 in a Phase 1/2 Clinical Trial in Advanced Solid Tumors or Lymphomas

December 22, 2022
Business Services

Nantes, France – December 22,

News
Press release

Innovative Antibody Discovered by RQ Bio Enters Clinic as Part of Antibody Combination Within 12 Months of Discovery

December 21, 2022
Medical Communications

LONDON, UK, 21st December 2022 — RQ Bio announces that the first of its discovered monoclonal antibodies to prevent COVID-19 …

News
Press release

Kite set to acquire Tmunity Therapeutics

December 21, 2022
Medical Communications

Santa Monica, US-based Kite is set to acquire Philadelphia, US-based Tmunity Therapeutics: a clinical stage, private biotech company. The financial …

News

Two biotech CEOs charged with defrauding investors over investigational HIV drug

December 21, 2022
Medical Communications

Two US biotech CEOs have been highlighted for their roles in a conspiracy to defraud investors in CytoDyn, a company …

News

Gambia panel recommends Maiden Pharmaceuticals be held culpable for cough syrup deaths

December 21, 2022
Medical Communications

A parliamentary committee in The Gambia has recommended prosecution of the Indian pharma manufacturer Maiden Pharmaceuticals, as they have sold …

News

Tamiflu manufacturers report shortages during high point of flu season

December 21, 2022
Medical Communications

The CDC has reported at least 23,000 hospitalisations due to influenza while this year’s flu season is at a high …

News

Sosei Heptares’ Partner Pfizer Progresses its Oral GLP-1 Receptor Agonist PF-07081532 into Phase 2 Clinical Trials for Treating Type 2 Diabetes and Obesity

December 21, 2022
Business Services

Tokyo, Japan and Cambridge, UK, 21 December 2022 – Sosei Group Corporation (“the Company”; TSE: 4565), the world leader in …

News
Press release

Poolbeg identifies new potential drug candidates for Respiratory Syncytial Virus infections as part of Artificial Intelligence Programme

December 21, 2022
Business Services

Poolbeg Pharma (AIM: POLB, OTCQB: POLBF, ‘Poolbeg’ or the ‘Company’), a leading infectious disease focused biopharmaceutical company, announces that it …

News
Press release

NICE EXTENDS USE OF ENHERTU® ▼ (TRASTUZUMAB DERUXTECAN) TO EARLIER IN THE TREATMENT OF HER2 POSITIVE METASTATIC BREAST CANCER

December 20, 2022
Business Services

Uxbridge and London, UK – (20 December 2022) – Daiichi Sankyo UK Limited and AstraZeneca UK Limited today welcome the …

News
Press release

Idorsia submits new drug application to FDA for aprocitentan to treat difficult-to-control hypertension

December 20, 2022
Research and Development

Idorsia has announced that it has submitted a new drug application (NDA) to the FDA in hopes of gaining approval …

News

AlzeCure has abstract accepted on possible disease-modifying effects of ACD856 against Alzheimer’s

December 20, 2022
Research and Development

AlzeCure, a pharma company who focuses on its portfolio of small molecule candidate drugs for central nervous system (CNS) diseases, …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026